Equine Veterinary Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2030

Equine Veterinary Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2030

Equine Veterinary Therapeutic Trends and Forecast

The future of the global equine veterinary therapeutic market looks promising with opportunities in the veterinary hospital, veterinary clinic, pharmacy and drug store, and e-commerce markets. The global equine veterinary therapeutic market is expected to grow with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rise in horse racing and other equestrian activities, the growing prevalence of equine ailments, and the rising costs associated with novel treatments' research and development.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Equine Veterinary Therapeutic by Segment

The study includes a forecast for the global equine veterinary therapeutic by drug, vaccines, route of administration, distribution channel, and region.

Equine Veterinary Therapeutic Market by Drug [Shipment Analysis by Value from 2018 to 2030]:

• Anti- Inflammatory
• Anti - Infective
• Parasiticides
• Others

Equine Veterinary Therapeutic Market by Vaccines [Shipment Analysis by Value from 2018 to 2030]:

• Recombinant Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• Others

Equine Veterinary Therapeutic Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Parental
• Topical

Equine Veterinary Therapeutic Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Veterinary Hospital
• Veterinary Clinics
• Pharmacies & Drug Stores
• E-Commerce
• Others

Equine Veterinary Therapeutic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Equine Veterinary Therapeutic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies equine veterinary therapeutic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the equine veterinary therapeutic companies profiled in this report include-

• Merck Animal Heath
• Affymetrix
• Elanco Animal Health
• Zoetis (Pfizer Animal Health)
• Equine Health

Equine Veterinary Therapeutic Market Insights

Lucintel forecasts that topical is expected to witness the highest growth over the forecast period due to growing demand for anti-infective, pain relievers, and digestive aid products.

North America will remain the largest region over the forecast period due to growing demand for anti-infective, vaccinations, pain medications, digestive aids, and strong research and development industry in the region.

Features of the Global Equine Veterinary Therapeutic Market

Market Size Estimates: Equine veterinary therapeutic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Equine veterinary therapeutic market size by drug, vaccines, route of administration, distribution channel, and region in terms of value ($B).

Regional Analysis: Equine veterinary therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug, vaccines, route of administration, distribution channel, and regions for the equine veterinary therapeutic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the equine veterinary therapeutic market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for equine veterinary therapeutic market?

Answer: The global equine veterinary therapeutic market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the equine veterinary therapeutic market?

Answer: The major drivers for this market are rise in horse racing and other equestrian activities, the growing prevalence of equine ailments, and the rising costs associated with novel treatments' research and development.

Q3. What are the major segments for equine veterinary therapeutic market?

Answer: The future of the global equine veterinary therapeutic market looks promising with opportunities in the veterinary hospital, veterinary clinic, pharmacy and drug store, and e-commerce markets.

Q4. Who are the key equine veterinary therapeutic market companies?

Answer: Some of the key equine veterinary therapeutic companies are as follows:

• Merck Animal Heath
• Affymetrix
• Elanco Animal Health
• Zoetis (Pfizer Animal Health)
• Equine Health

Q5. Which equine veterinary therapeutic market segment will be the largest in future?

Answer: Lucintel forecasts that topical is expected to witness the highest growth over the forecast period due to growing demand for anti-infective, pain relievers, and digestive aid products.

Q6. In equine veterinary therapeutic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing demand for anti-infective, vaccinations, pain medications, digestive aids, and strong research and development industry in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the equine veterinary therapeutic market by drug (anti- inflammatory, anti - infective, parasiticides, and others), vaccines (recombinant vaccines, inactivated vaccines, live attenuated vaccines, and others), route of administration (oral, parental, and topical), distribution channel (veterinary hospital, veterinary clinics, pharmacies & drug stores, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?